SELLAS Life Sciences (SLS) Notes Payables (2011)
SELLAS Life Sciences' (SLS) quarterly Notes Payables came in at $500000.0 in Q4 2011, little changed on a QoQ basis from $500000.0 in Q3 2011.
SELLAS Life Sciences (SLS) Notes Payables (2011) Analysis & Trends
SELLAS Life Sciences (SLS) has 1 years of Notes Payables data on file, last reported at $500000.0 in Q4 2011.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $500000.0 in Q4 2011; TTM through Dec 2011 was $500000.0, a N/A change from a year earlier, with the FY2011 full-year figure at $500000.0, changed N/A from the prior year.
- Notes Payables for Q4 2011 stood at $500000.0, roughly flat from $500000.0 in the prior quarter.
- Over the last five years, Notes Payables for SLS reached as high as $500000.0 in Q3 2011 and fell as low as $500000.0 in Q3 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 500,000.00 |
| Sep 30, 2011 | 500,000.00 |